For my part, I am confident that there will be a significant share price appreciation the closer we get to the readout. Don't sweat it. But usually this happens gradually. I imagine that the company is currently focussed on finishing the trial, but once recruitment is complete will start to focus again on getting the story out there via interviews / analyst reports or other means. There has not been too much point having a new interview recently as it only would have said the same as the last one "we are recruiting". It will have more impact to sit in front of a camera after recruitment is complete and say "our recruitment is complete, we have x participants and the last will finish treatment on... therefore we expect readout around ..." than say " we have closed off screening therefore we should finish recruitment soon and after that we can determine when we should get the results".
FTT Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held